==============================
                                                          OMB APPROVAL
                                                  ==============================
                                                  OMB Number:          3235-0080

                                                  Expires:      January 31, 2008

                                                  Estimated average burden
                                                  hours per response         1.7
                                                  ==============================

                                  UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                     FORM 25

            NOTIFICATION OF REMOVAL FROM LISTING AND/OR REGISTRATION
           UNDER SECTION 12(b) OF THE SECURITIES EXCHANGE ACT OF 1934.

                        Commission File Number 000-23016

--------------------------------------------------------------------------------
                       Issuer:   Medifast, Inc.
                       Exchange: American Stock Exchange
--------------------------------------------------------------------------------
             (Exact name of Issuer as specified in its charter, and
          name of Exchange where security is listed and/or registered)

--------------------------------------------------------------------------------
                       Address:          11445 Cronhill Drive
                                         Owings Mills, Maryland 21117
                       Telephone number: 410-581-8042
--------------------------------------------------------------------------------
    (Address, including zip code, and telephone number, including area code,
                    of Issuer's principal executive offices)

--------------------------------------------------------------------------------
                          Common Stock, par value $.001
--------------------------------------------------------------------------------
                      (Description of class of securities)

Please place an X in the box to designate the rule provision relied upon to
strike the class of securities from listing and registration:

      |_|   17 CFR 240.12d2-2(a)(1)

      |_|   17 CFR 240.12d2-2(a)(2)

      |_|   17 CFR 240.12d2-2(a)(3)

      |_|   17 CFR 240.12d2-2(a)(4)

      |_|   Pursuant to 17 CFR 240.12d2-2(b), the Exchange has complied with its
            rules to strike the class of securities from listing and/or withdraw
            registration on the Exchange. (1)

      |X|   Pursuant to 17 CFR 240.12d2-2(c), the Issuer has complied with its
            rules of the Exchange and the requirements of 17 CFR 240.12d-2(c)
            governing the voluntary withdrawal of the class of securities from
            listing and registration on the Exchange.


Pursuant to the requirements of the Securities Exchange Act of 1934, Medifast,
Inc. certifies that it has reasonable grounds to believe that it meets all of
the requirements for filing the Form 25 and has caused this notification to be
signed on its behalf by the undersigned duly authorized person.

  --------------------        --------------------        --------------------
      2006-08-24          By    Michael McDevitt            President & CFO
  --------------------        --------------------        --------------------
        Date                         Name                        Title